Codice QR

Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine

<p>Abstract</p> <p>Background</p> <p>Currently licensed human vaccines are subtype-specific and do not protect against pandemic H5N1 viruses. Previously, our group has reported on the construction of an influenza virus-like particle (VLP) as a new generation candidate vaccine. A mixture of influenza...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Ross Ted M, Crevar Corey J
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMC 2008-10-01
Serie:Virology Journal
Accesso online:http://www.virologyj.com/content/5/1/131
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!